The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition

Magdalini Rapti, Susan J. Atkinson, Meng Huee Lee, Andrew Trim, Marcia Moss, Gillian Murphy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)

Abstract

ADAM (a disintegrin and metalloproteinase) 10 is a key member of the ADAM family of disintegrin and metalloproteinases which process membrane-associated proteins to soluble forms in a process known as 'shedding'. Among the major targets of ADAM10 are Notch, EphrinA2 and CD44. In many cell-based studies of shedding, the activity of ADAM10 appears to overlap with that of ADAM17, which has a similar active-site topology relative to the other proteolytically active ADAMs. The tissue inhibitors of metalloproteinases, TIMPs, have proved useful in the study of ADAM function, since TIMP-1 inhibits ADAM10, but not ADAM17; however, both enzymes are inhibited by TIMP-3. In the present study, we show that, in comparison with ADAM17 and the MMPs (matrix metalloproteinases), the N-terminal domains of TIMPs alone are insufficient for the inhibition of ADAM10. This knowledge could form the basis for the design of directed inhibitors against different metalloproteinases.

Original languageEnglish
Pages (from-to)433-439
Number of pages7
JournalBiochemical Journal
Volume411
Issue number2
DOIs
Publication statusPublished - 15 Apr 2008
Externally publishedYes

Keywords

  • ADAM10
  • CD44
  • Inhibition
  • Shedding
  • Tissue inhibitor of metalloproteinase (TIMP)
  • Tumour necrosis factor α converting enzyme (TACE)

Cite this